Myricadiol; 蒲公英赛-14-烯-3beta,28-二醇 | 17884-88-7

• 物质功能分类: 天然产物 - 萜类
• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 中文名称: Myricadiol; 蒲公英赛-14-烯-3beta,28-二醇
• 中文别名: 蒲公英赛-14-烯-3BETA,28-二醇；Myricadiol;蒲公英赛-14-烯-3beta,28-二醇
• 英文名称: myricadiol
• 英文别名: (3S,4aR,6aR,6aS,8aS,12aS,14aR,14bR)-8a-(hydroxymethyl)-4,4,6a,6a,11,11,14b-heptamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-ol
• CAS: 17884-88-7
• 化学式: C₃₀H₅₀O₂
• 分子量: 442.726
• InChiKey: RJAKLUPHSBOQNU-GCHNNGBASA-N

物化性质

• 熔点：
  262-263 °C
• 沸点：
  520.5±50.0 °C(Predicted)
• 密度：
  1.05±0.1 g/cm3(Predicted)
• LogP：
  9.171 (est)

计算性质

• 辛醇/水分配系数(LogP)：
  7.9
• 重原子数：
  32
• 可旋转键数：
  1
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.93
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  Myricadiol; 蒲公英赛-14-烯-3beta,28-二醇 在 chromium(VI) oxide 作用下， 生成 Myriconal
  参考文献：
  名称：

  Rjabinin; Matjuchina, Doklady Akademii Nauk SSSR, 1959, vol. 129, p. 125

  摘要：

  DOI：
• 作为产物：
  描述：

  (4aR,6aR,6bR,8aR,10S,12aR,14aS,14bS)-10-hydroxy-2,2,6b,9,9,12a,14a-heptamethyl-1,3,4,5,6a,7,8,8a,10,11,12,13,14,14b-tetradecahydropicene-4a-carbaldehyde 、 硼氢化钠 生成 Myricadiol; 蒲公英赛-14-烯-3beta,28-二醇
  参考文献：
  名称：

  YAGUCHI, YOSHIKATSU;SAKURAI, NOBUKO;NAGAI, MASAHIRO;INOUE, TAKAO, CHEM. AND PHARM. BULL., 36,(1988) N 4, 1419-1424

  摘要：

  DOI：

文献信息

• Further preparations of silk proteins, seed oils, monosaccharide, natural botanicals and polysaccharide mixtures in compositions for hair care or hair repair, and skin care and topical treatments
  申请人：Ross Valerie M.

  公开号：US10456345B2

  公开（公告）日：2019-10-29

  The present invention intends to provide a composition for hair and skin treatment containing a combination consisting of silk amino acid and protein complexes, seed oils, polysaccharides, polyol, monosaccharide, and botanicals. The composition for hair and skin treatment containing the combination consisting of silk amino acid and protein complexes, seed oils, polysaccharides, and botanicals has excellent improvement effects on the condition of the hair follicle and cuticle, imparts moisture to dry hair; thereby reducing the damaging effects of psoriasis, eczema, alopecia, and seborrheic dermatitis. Furthermore, it imparts retention of moisture to the skin resulting in an improved appearance and diminished appearance of lines on the skin. This invention relates to the manufacture of personal care products to be applied to the hair and skin. The compositions may be in the form of hair conditioners, hair growth treatments, shampoos, skin care, skin cleansing, or anti-wrinkle products, and ointments.

  本发明旨在提供一种用于头发和皮肤治疗的组合物，该组合物含有由蚕丝氨基酸和蛋白复合物、种子油、多糖、多元醇、单糖和植物药组成的复合物。含有蚕丝氨基酸和蛋白质复合物、种子油、多糖和植物成分的头发和皮肤治疗组合物对毛囊和角质层的状况有很好的改善作用，能为干燥的头发提供水分，从而减少牛皮癣、湿疹、脱发和脂溢性皮炎的破坏作用。此外，它还能保持皮肤水分，从而改善皮肤外观，减少皮肤纹路。本发明涉及用于头发和皮肤的个人护理产品的制造。这些组合物可以是护发素、生发护理剂、洗发水、皮肤护理、皮肤清洁或抗皱产品以及软膏。
• Methods of producing a functionalized coffee
  申请人：Brucker Donald

  公开号：US20050031761A1

  公开（公告）日：2005-02-10

  The disclosure provides a functionalized coffee composition comprising one or more non-vitamin, non-mineral functional additives. In some aspect, vitamins and/or minerals may be provided in the functionalized coffee compositions. The disclosure also includes methods of making a functionalized coffee composition and coffee beverages made therefrom.

  本公开提供了一种包含一种或多种非维生素、非矿物质功能添加剂的功能化咖啡组合物。在某些方面，可在功能化咖啡组合物中提供维生素和/或矿物质。本公开还包括制作功能化咖啡组合物和咖啡饮料的方法。
• METHODS OF PRODUCING A FUNCTIONALIZED COFFEE
  申请人：Sunrise Coffee Co

  公开号：EP1659876A2

  公开（公告）日：2006-05-31
• Functionalized coffee
  申请人：Brucker Donald

  公开号：US20080057162A1

  公开（公告）日：2008-03-06

  The disclosure provides a functionalized coffee composition comprising one or more non-vitamin, non-mineral functional additives. In some aspects, vitamins and/or minerals may be provided in the functionalized coffee compositions. The disclosure also includes methods of making a functionalized coffee composition and coffee beverages made therefrom.
• COMPOSITIONS FROM WAX MYRTLE FOR THE TREATMENT OF CANCER, CARDIOVASCULAR AND INFLAMMATORY DISEASES
  申请人：Dev Inderjit Kumar

  公开号：US20090022821A1

  公开（公告）日：2009-01-22

  The present invention relates to the use of certain novel compositions from wax myrtle ( Morella cerifera ) which are inhibitors of nuclear factor kappa B (NF-kB), oxidative stress (activation of Nerf2) and the activity of the endothelin receptor. In particular, it relates to useful enriched fractions and pharmaceutical compositions from wax myrtle for use in the treatment of cardiovascular and inflammatory diseases and for cancers susceptible to an inhibitor of oxidative stress (activation of Nerf2), NF-kB inhibitor and an endothelin receptor inhibitor. The present invention also relates to compositions from wax myrtle useful to inhibit cell proliferation and for the induction of apoptosis.